期刊文献+

胰高血糖素样肽-2对幼鼠肠缺血-再灌注损伤的保护作用 被引量:3

Protective effects of glucagon-like peptide 2 on intestinal ischemia-reperfusion injury of young rats
原文传递
导出
摘要 目的研究胰高血糖素样肽2(GLP-2)对肠缺血-再灌注(I-R)幼鼠肠屏障功能的保护作用。方法采用肠I-R模型,将24只雄性Wistar幼鼠随机均分为假手术(C组)、肠I-R损伤(B组)和肠I-R损伤+GLP-2保护(A组)三组。光镜下观察小肠黏膜形态学改变,检测肠系膜淋巴结的细菌菌落情况、肠黏膜丙二醛(MDA)、血清D-乳酸、内毒素和肿瘤坏死因子α(TNF-α)水平的变化。结果B组肠黏膜损伤最明显,Chiu′s评分、肠系膜淋巴结细菌菌落计数、肠黏膜MDA、血清D-乳酸、内毒素和TNF-α水平均显著高于C组(P<0.01);与B组相比,A组肠黏膜损伤明显减轻,且Chiu′s评分、肠系膜淋巴结细菌菌落计数、肠黏膜MDA、血清D-乳酸、内毒素和TNF-α水平显著降低(P<0.05)。结论GLP-2能够减轻幼鼠肠I-R损伤、保护肠黏膜屏障、减轻细菌/内毒素易位、减少氧自由基和炎性介质的产生和释放。 Objective To explore the protective effects of glucagon-like peptide 2 (GLP-2) on intestinal ischemia-reperfusion(I-R)injury of young rats. Methods Using the rat model of intestinal ischemia-reperfusion,24 young male Wista rats were randomly assigned to three groups of sham operation(group C),I-R(group B) and I-R+GLP-2(group A) with 8 rats each. Intestinal pathology was examined under light microscope. Bacterial colony of mesenteric lymph node(MLN), intestinal mucosal malondialdehyde(MDA), serum D-lactate, endotoxin, and tumor necrosis factoe(TNF)-α were studied. Results The intestinal injury was significant in group B, and Chiu's scores, bacterial colony counts of MLN, intestinal mucosal MDA, serum D-lactate, endo;cgxin, and TNF-α were also significantly higher in group B than those in group C (P〈0. 01), which were significantly lower in group A than those in group B (P〈0. 05 ). Conclusion GLP-2 attenuates intestinal I-R injury, protects intestinal mueosal barrier, reduces bacterial/endotoxin translocation, inhibits the release of oxygen free radicles and inflammatory eytokines.
出处 《江苏医药》 CAS CSCD 北大核心 2009年第12期1473-1475,共3页 Jiangsu Medical Journal
关键词 胰高血糖素样肽2 肠缺血-再灌注损伤 D-乳酸 细菌易位 Glucagon-like peptide 2 Intestinal ischemia-reperfusion injury D-lactate Bacterial translocation
  • 相关文献

参考文献10

  • 1Burrin DG, Stoll B, Guan X. Glucagon-like peptide 2 function in domestic animals [J]. Domest Anim Endocrinol, 2003, 24 (2) : 103-122.
  • 2Burrin DG, Stoll B, Guan X, et al. Glucagon-like peptide 2 dose-dependently activates intestinal cell survival and proliferation in neonatal piglets[J] Endocrinology, 2005,146 ( 1 ) : 22- 32.
  • 3Torres S, Thim L, Milliat F, et al. Glucagon-like peptide-2 improves both acute and late experimental radiation enteritis inthe rat[J]. Int J Radiat Oncol Biol Phys,2007,69(5): 1563- 1571.
  • 4赵云,王凤君,王裴,陈渝,汪仕良.重组胰高血糖素样多肽2对烧伤大鼠肠黏膜的保护作用[J].中华烧伤杂志,2007,23(4):253-256. 被引量:2
  • 5Chiu CJ, McArdle AH, Brown R, et al. Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal[J]. Arch Surg, 1970,101 (4) : 478- 483.
  • 6Diepenhorst GM, van Gulik TM, Hack CE. Complementmediated isehemia-reperfusion injury:lessons learned from animal and clinical studies[J]. Ann Surg, 2009,249(6) : 889- 899.
  • 7Boushey RP, Yusta B, Drucker DJ. Glucagon-like peptide 2 decreases mortality and reduces the severity of indomethacin- induced murine enteritis [J ]. Am J Physiol Endocfinol Metab, 1999,277(5) : 937-947.
  • 8Tavakkolizadeh A, Shen R, Abraham P, et al. Glucagon-like peptide 2..a new treatment for chemotherapy-induced enteritis [J]. J Surg Res,2000,91(1).-77-82.
  • 9Herrera DJ, Morris K,Johnston C, et al. Automated assay for plasma D-lactate by enzymatic spectrophotometric analysis with sample blank correction[J]. Ann Clin Biochem, 2008,45 (2):177-183.
  • 10Ozturk H,Yagmur Y, Ozturk H. The prognostic importance of serum IL-1beta, IL-6, IL-8 and TNF-alpha levels compared to trauma scoring systems for early mortality in children with blunt trauma[J]. Pediatr Surg Int, 2008,24 (2) : 235-239.

二级参考文献13

  • 1Drucker DJ, Erlich P, Asa SL, et al. Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci, 1996,93 ( 7 ) :7911 - 7916.
  • 2Benjamin MA, MeKay DM, Yang PC, et. al. Glucagon-like peptide-2 enhances intestinal epithelial barrier function of both transcellular and paracellular pathways in the mouse. Gut,2000,47( 1 ) : 112 - 119.
  • 3Gleeson MH, Bloom SR, Polak JM. Endocrine tumour in kidney affecting small bowel structure, motility, and absorptive function. Gut,1971,12(2) :773 -782.
  • 4Martin GR. WaLlace LE, Sigalet DL. Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome. Am J Physiol Gastrointest Liver Physiol, 2004, 286( 3 ) :964 -972.
  • 5Shin ED, Estall JL,Izzo A, at al. Mueosal adaptation to enteral nutrients is dependent on the physiologic actions of glucagon-like peptide-2 in mice. Gasteroenterology, 2005, 128 (5) : 1340 - 1353.
  • 6Jasleen JN, Ashley SW, Shimoda N ,et al. Glueagon-like peptide 2 stimulates intestinal epithelial proliferation in vitro. Dig Dis Sci,2002, 47(5): 1135-1140.
  • 7Jeppesen PB, Hartmann B ,Thulesen J,et. al. Glucagonlike peptide 2 improves nutrient absorption and nutritional status in shortbowel patients with no colon. Gastroenterology, 2001,120(3) :806-815.
  • 8Burrin DG, Stoll B, Jiang R, et al. GLP-2 stimulates intestinal growth inpremature TPN-fed pigs by suppressing proteolysis and apoptosis. Am J Physiol ( Gastrointest Liver Physiol) , 2000, 279 (7) :1249 - 1256.
  • 9Latham PW. Therapeutic peptides revisited. Nat Biotechnol, 1999, 17(8) :755 -757.
  • 10朱振洪.国内外基因工程制药综述[J].生物技术,2001,11(6):36-38. 被引量:2

共引文献1

同被引文献47

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部